Telotristat ethyl (LX1606) is an orally active small molecule inhibitor of tryptophan hydroxylase, the rate-limiting enzyme in serotonin biosynthesis. It is used in research to modulate serotonin levels for in vitro and in vivo studies, particularly in models of carcinoid syndrome and gastrointestinal disorders.